Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06872866 · ClinicalTrials.gov registry record · Phase 1

The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects

A Phase 1 study of Erectile Dysfunction, sponsored by Aspargo Labs.

Recruiting
Registry status
Phase 1
Development phase
12
Enrollment target
1
Study location

NCT06872866 is a Phase 1 study of Erectile Dysfunction that is actively recruiting participants, run by Aspargo Labs. The registered enrollment target is 12 participants, below the 231-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06872866, a Phase 1 study of Erectile Dysfunction, is actively recruiting participants, sponsored by Aspargo Labs.

RECRUITING
Registry status
Phase 1
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The objective of this phase 1 study is to evaluate the food effect of 100 mg Hezkue Turbo® (ASP-001.1, sildenafil) under fed versus 100 mg of Hezkue Turbo® (ASP-001.1, sildenafil) under fasted conditions in healthy adult male subjects

Conditions Studied

Erectile Dysfunction

Interventions

  • DRUG ASP-001.1
  • DEVICE ASP-001.1

Study Locations (1)

New York

  • Aspargo Labs - New York

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2025-04-15
Est. Completion 2026-02-28
Phase Phase 1

Sponsor

Aspargo Labs

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06872866

The ClinicalTrials.gov registry entry for NCT06872866 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 231-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (95% lower). The listed sponsor is Aspargo Labs, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Erectile Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which ASP-001.1 is the first listed.

NCT06872866 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06872866 about?

NCT06872866 is a clinical study titled "The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects". The objective of this phase 1 study is to evaluate the food effect of 100 mg Hezkue Turbo® (ASP-001.1, sildenafil) under fed versus 100 mg of Hezkue Turbo® (ASP-001.1, sildenafil) under fasted conditions in healthy adult male subjects

What is the current status of trial NCT06872866?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2025-04-15. Estimated completion is 2026-02-28.

What conditions does trial NCT06872866 study?

This clinical trial studies the following conditions: Erectile Dysfunction.

What interventions are being tested in trial NCT06872866?

The interventions under investigation include: ASP-001.1 (DRUG), ASP-001.1 (DEVICE).

Who is sponsoring clinical trial NCT06872866?

This trial is sponsored by Aspargo Labs, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06872866 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Erectile Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Erectile Dysfunction

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.